SciSparc updates director ownership details

SciSparc Ltd. director Revach Moshe filed an amended initial ownership report updating his beneficial holdings.

Rhea-AI Filing Summary

SciSparc Ltd. director Revach Moshe filed an amended initial ownership report updating his beneficial holdings. Moshe now reports 3,649 Ordinary Shares directly owned, including 3,333 Ordinary Shares issuable from restricted share units (RSUs) vesting in quarterly installments of 417 shares through December 18, 2027, and 316 Ordinary Shares issuable from RSUs vesting in equal quarterly installments of 40 shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share. In addition, Moshe holds a stock option to acquire 1 Ordinary Share at an exercise price of 31,941, expiring January 3, 2028.

Filing Explained

The director’s reported position is 3,649 ordinary shares plus a right to buy one share; the filing updates ownership records rather than reporting a transaction.

The July 13, 2026 Form 3/A amends the director’s initial ownership statement for the March 18, 2026 event date and updates the reported beneficial-ownership record rather than documenting a new issuer transaction.

It reports 3,649 ordinary shares beneficially owned directly, including 3,333 ordinary shares issuable as restricted share units vest and 316 ordinary shares issuable under another RSU schedule.

The RSUs are scheduled to vest in quarterly installments through December 18, 2027 and June 20, 2026, respectively; the filing also reports a stock option for one underlying ordinary share, exercisable through January 3, 2028, at an exercise price of $31,941.

Accordingly, the filing identifies reported ownership and potential share-delivery rights, but does not state that the option was exercised or that an issuer share transaction occurred.

Sources and calculations

• SciSparc Form 3/A — Amended Initial Statement of Beneficial Ownership (2026-07-13)

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Revach Moshe

Role Director

Type	Security	Shares	Price	Value
holding	Stock option (right to buy) F2	--	--	--
holding	Ordinary Shares F1	--	--	--

Holdings After Transaction: Stock option (right to buy) — 1 contracts (Direct); Ordinary Shares — 3,649 shares (Direct)

Footnotes (2)

1. F1. This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends the total number of securities beneficially owned by the reporting person in Table I, and amends and restates the first footnote in Table I as follows: "Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 417 Ordinary Shares through December 18, 2027; and (ii) 316 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 40 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share."
2. F2. This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.

Key Figures

Ordinary Shares beneficially owned: 3,649 shares RSUs vesting through December 18, 2027: 3,333 Ordinary Shares RSUs vesting through June 20, 2026: 316 Ordinary Shares +3 more

6 metrics

Ordinary Shares beneficially owned 3,649 shares Total Ordinary Shares beneficially owned by Revach Moshe after amendment

RSUs vesting through December 18, 2027 3,333 Ordinary Shares RSUs vesting in quarterly installments of 417 Ordinary Shares

RSUs vesting through June 20, 2026 316 Ordinary Shares RSUs vesting in equal quarterly installments of 40 Ordinary Shares

Stock option exercise price 31,941 Exercise price for stock option to acquire 1 Ordinary Share

Stock option expiration January 3, 2028 Expiration date of stock option held by Revach Moshe

Underlying shares for option 1 Ordinary Share Underlying Ordinary Shares for the reported stock option

Key Terms

restricted share units ("RSUs"), beneficially owned, Stock option (right to buy), Ordinary Shares

4 terms

restricted share units ("RSUs") financial

"Includes (i) 3,333 ordinary shares... issuable upon the vesting of restricted share units ("RSUs")"

beneficially owned financial

"amends the total number of securities beneficially owned by the reporting person in Table I"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Stock option (right to buy) financial

"Stock option (right to buy) ... underlying security title Ordinary Shares"

Ordinary Shares financial

"3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares")"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SciSparc (SPRC) director Revach Moshe report owning in this Form 3/A?

Revach Moshe reports 3,649 Ordinary Shares beneficially owned, including Ordinary Shares issuable from RSUs that vest through June 20, 2026 and December 18, 2027, plus a stock option for 1 Ordinary Share.

How many RSUs does SciSparc (SPRC) director Revach Moshe hold and how do they vest?

Moshe holds RSUs for 3,333 Ordinary Shares vesting in quarterly installments of 417 shares through December 18, 2027, and RSUs for 316 Ordinary Shares vesting in equal quarterly installments of 40 shares through June 20, 2026.

What stock option position does Revach Moshe report in SciSparc (SPRC)?

Moshe reports a stock option to buy 1 Ordinary Share of SciSparc, with an exercise price of 31,941 and an expiration date of January 3, 2028, held directly.

What is the purpose of this SciSparc (SPRC) Form 3/A amendment?

The amendment updates the total number of securities beneficially owned in Table I and fully amends and restates Table II of the initial Form 3, without changing other original footnotes.

How are RSUs defined for SciSparc (SPRC) director Revach Moshe in this filing?

Each restricted share unit (RSU) is defined as representing the right to receive one Ordinary Share of SciSparc upon vesting, with vesting occurring in specified quarterly installments through 2026 and 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 07:07 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Revach Moshe

(Last) (First) (Middle)

20 RAUL WALLENBERG STREET

TOWER A, TEL AVIV, ISRAEL

(Street)

TEL AVIV 6971916

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SciSparc Ltd. [ SPRC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,649(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	01/03/2022	01/03/2028	Ordinary Shares	1(2)	$31,941	D

Explanation of Responses:

1. This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends the total number of securities beneficially owned by the reporting person in Table I, and amends and restates the first footnote in Table I as follows: "Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 417 Ordinary Shares through December 18, 2027; and (ii) 316 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 40 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share."

2. This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.

	/s/ Moshe Revach	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)